The vascular shutdown caused by treatment with VDAs such as DMXAA has been shown to be associated with the establishment of hypoxic and necrotic areas in the tumour, which would induce the activation of HIF-1α protein, subsequently leading to the development of new blood vessels and immunosuppression, promoting tumour regrowth. Here, HIF1A is linked to neoplasm.